[Long-term administration of Dalteparin in unstable coronary syndrome. FRISC II study opens novel therapeutic perspectives. Fragmin and Fast Revascularization during Instability in Coronary Artery Disease].
Arnheim
K
K
D000789:Angina, Unstable / Q000150:complications / Q000188:drug therapy*; D000925:Anticoagulants / Q000008:administration & dosage*; D018849:Controlled Clinical Trials as Topic; D017985:Dalteparin / Q000008:administration & dosage*; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D004334:Drug Administration Schedule; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control*; D016019:Survival Analysis; D013577:Syndrome; D016896:Treatment Outcome
D000925:Anticoagulants; D017985:Dalteparin